Monopar Therapeutics Inc (MNPR) Live Share Price, Invest From India

Monopar Therapeutics Inc Stock Performance

as on March 28, 2026 at 6:59 am IST

Day's Low
Day's High
$53.84
Day's Price Range
$57.47
$54.30
0.85%
Downside
5.84%
Upside
52 Week's Low
52 Week's High
$26.06
52-Week Price Range
$105.00
$54.30
52.02%
Downside
93.37%
Upside

Monopar Therapeutics Inc share price movements today

Previous Close: $54.56
Open: $54.40
Volume: 261.2K
Day's Low - High: $53.84 - $57.47
52 Week Low - High: $26.06 - $105.00

Monopar Therapeutics Inc Historical Returns

1 Month Return: -1.29 %
3 Month Return: -21.33 %
1 Year Return: + 34.14 %
3 Year Return: + 646.21 %
5 Year Return: + 69.73 %

Monopar Therapeutics Inc Stock Fundamentals & Key Indicators

Check Monopar Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$364.6M

EPS (TTM)

-1.6724

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-26.54%

Monopar Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Monopar Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Monopar Therapeutics Inc	BUY	$364.6M	69.73%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$43.5B	132.92%	140.84	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$115.2B	101.77%	29.58	32.94%
Beone Medicines Ltd	NA	$31.8B	NA	112.58	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$80.0B	54.69%	18.25	31.41%

Stock Returns calculator for Monopar Therapeutics Inc Stock including INR - Dollar returns

The Monopar Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Monopar Therapeutics Inc investment value today

Current value as on today

₹1,45,267

Returns

₹45,267

(+45.27%)

Returns from Monopar Therapeutics Inc Stock

₹34,639 (+34.64%)

Dollar Returns*

₹10,628 (+10.63%)

Analyst Recommendation on Monopar Therapeutics Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Monopar Therapeutics Inc. Average target price of $112

Monopar Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Monopar Therapeutics Inc.

What analysts predicted

51.52%UPSIDE

Target Price

$112

Current Price

$54.3

Analyzed by

8 Analysts

Target

$112.00

Monopar Therapeutics Inc target price $112, a slight upside of 51.52% compared to current price of $54.3. According to 8 analysts rating.

Monopar Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Monopar Therapeutics Inc Stock has decreased by -39% in the last 30 days, reflecting a downward trend in search activity.

Time period: February 27, 2026 to March 29, 2026

Change:-39% versus previous 30 day period

Monopar Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-2	-2	-1	-1	-1	-1	-11	-3	-3	-4
EBITDA	-2	-2	-1	-1	-1	-1	-10	-3	-2	-3
Interest Expense	-	-	0	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-2	-1	-1	-1	-1	-1	-10	-2	-2	-3
Income Tax Expense	128	112	0	-1	-1	-	-	-	-	-
Net Income	-2	-1	-1	-1	-1	-1	-10	-2	-2	-3
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Monopar Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	0	-	-	-	-
Gross Profit	-	-	-	-	0	-	-	-	-
Operating Income	-1	-16	-3	-4	-6	-9	-10	-8	-16
EBITDA	-1	-16	-3	-4	-6	-9	-10	-8	-16
Interest Expense	0	0	0	0	0	0	0	-	-
Depreciation	-	-	-	-	-	-	-	-	-
Income Before Tax	-1	-16	-3	-4	-6	-9	-10	-8	-15
Income Tax Expense	0	-2	0	0	0	0	0	0	-
Net Income	-1	-16	-3	-4	-6	-9	-10	-8	-15
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-5150.79%	0.00%	0.00%	0.00%	0.00%

Monopar Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-1	-1	-1	-1	-1	-10	-2	-2	-3
Operating Cash Flow	-1	-1	-1	-1	-1	-1	-5	-1	-2
Investing Cash Flow	0	2	0	0	0	-14	0	1	-2
Financing Cash Flow	0	0	3	0	0	56	0	0	92
Change in Cash	-1	1	0	-1	0	39	-6	0	88

Monopar Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-1	-16	-3	-4	-6	-9	-10	-8	-15
Operating Cash Flow	-1	-2	-2	-3	-4	-7	-7	-7	-6
Investing Cash Flow	-	-	-	-	-	-	-4	4	-14
Financing Cash Flow	1	9	0	9	8	10	0	2	59
Change in Cash	0	6	-2	6	3	3	-12	0	38

Global Institutional Holdings in Monopar Therapeutics Inc

Funds	Holdings
RA Capital Management, LLC	9.98%
Charles Schwab Investment Management Inc	0.21%
Susquehanna International Group, LLP	0.14%
Adage Capital Partners Gp LLC	9.57%
Barclays PLC	0.12%

See all

Monopar Therapeutics Inc News & Key Events

Insights on Monopar Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 3 Years
In the last 3 years, MNPR has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, MNPR has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 3 years, MNPR stock has moved up by 631.1%

About Monopar Therapeutics Inc

monopar therapeutics inc., a biopharmaceutical company, engages in developing proprietary therapeutics to enhance clinical outcomes for cancer patients in the united states. it is involved in developing validive, a clonidine mucobuccal tablet that is in phase iii for the treatment of radiation induced severe oral mucositis in oropharyngeal cancer patients; camsirubicin, a topoisomerase ii-alpha targeted analog of doxorubicin engineered to retain anticancer activity and for minimizing toxic effects on the heart; and mnpr-101, a humanized monoclonal antibody for treating advanced solid cancers. the company has a collaboration grupo espaã±ol de investigaciã³n en sarcomas for the development of camsirubicin in patients with advanced soft tissue sarcoma; and northstar medical radioisotopes, llc to develop radio-immuno-therapeutics targeting severe covid-19. monopar therapeutics inc. was founded in 2014 and is headquartered in wilmette, illinois.

Organisation	Monopar Therapeutics Inc
Headquarters	1000 Skokie Boulevard, Wilmette, IL, United States, 60091
Industry	Health Technology
CEO	Dr. Chandler D. Robinson M.B.A., M.D., M.Sc.
E-voting on shares	Click here to vote

Key Management of Monopar Therapeutics Inc

Name	Title
Ms. Susan Rodriguez	Chief Commercial & Strategy Officer
Dr. Christopher M. Starr Ph.D.	Co-Founder & Independent Executive Chairman of the Board
Dr. Chandler D. Robinson M.B.A., M.D., M.Sc.	Co-Founder, CEO, President & Director
Mr. Andrew J. Cittadine M.B.A.	Chief Operating Officer
Mr. Quan Anh Vu	CFO, Principal accounting officer & Principal financial officer
Dr. Patrice P. Rioux M.D., Ph.D.	Acting Chief Medical Officer

FAQs

What is Monopar Therapeutics Inc share price today?

Monopar Therapeutics Inc share price today is $54.3 as on March 28, 2026 at 1:29 am IST at the close of the market. Monopar Therapeutics Inc share today touched a day high of $57.47 and a low of $53.84.

What is the 52 week high and 52 week low for Monopar Therapeutics Inc share?

Monopar Therapeutics Inc share touched a 52 week high of $105 on October 6, 2025 and a 52 week low of $26.06 on April 9, 2025. Monopar Therapeutics Inc stock price today i.e. March 28, 2026 at 1:29 am IST is closed at $54.3,which is 48.29% down from its 52 week high and 108.41% up from its 52 week low.

What is Monopar Therapeutics Inc's market capitalisation today?

Monopar Therapeutics Inc market capitalisation is $0.00T as on March 28, 2026 at 1:29 am IST.

How to invest in Monopar Therapeutics Inc Stock (MNPR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Monopar Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Monopar Therapeutics Inc Shares that will get you 0.0276 shares as per Monopar Therapeutics Inc share price of $54.3 per share as on March 28, 2026 at 1:29 am IST.

What is the minimum amount required to buy Monopar Therapeutics Inc Stock (MNPR) from India?

Indian investors can start investing in Monopar Therapeutics Inc (MNPR) shares with as little as ₹94.63 or $1 (as of March 29, 2026 at 1:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹946.30 in Monopar Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on March 29, 2026 at 1:42 pm IST). Based on Monopar Therapeutics Inc share’s latest price of $54.3 as on March 28, 2026 at 1:29 am IST, you will get 0.1842 shares of Monopar Therapeutics Inc. Learn more about fractional shares .

What are the returns that Monopar Therapeutics Inc has given to Indian investors in the last 5 years?

Monopar Therapeutics Inc stock has given 69.73% share price returns and 29.07% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?